The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the potential to avoid disfiguring lesions if used early.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/phase-3-trials-promise-better-options-shut-down-connective-2026a10002mg?src=rss
Author :
Publish date : 2026-01-27 21:57:00
Copyright for syndicated content belongs to the linked Source.
